Dr Charles Mittnacht Smith, MD | |
1101 Padre Kino, Santa Fe, NM 87501-2900 | |
(505) 992-1101 | |
(505) 992-1101 |
Full Name | Dr Charles Mittnacht Smith |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Location | 1101 Padre Kino, Santa Fe, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174873277 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | C1-0000685 (Delaware) | Secondary |
207R00000X | Internal Medicine | C1-0000685 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Charles Mittnacht Smith, MD 1101 Padre Kino, Santa Fe, NM 87501-2900 Ph: (505) 992-1101 | Dr Charles Mittnacht Smith, MD 1101 Padre Kino, Santa Fe, NM 87501-2900 Ph: (505) 992-1101 |
News Archive
A new type of CAR T-cell therapy more than triples the expected length of remission for multiple myeloma patients who have relapsed several times, according to an international clinical trial with UT Southwestern as the lead enrolling site.
A new study published in the Journal of Psychosomatic Obstetrics & Gynecology has found that women who suffer from pelvic pain caused by endometriosis may need psychological intervention in order to help improve their mental health and quality of life.
A recent Loyola Medicine study found that reducing the standard dose of IV-administered ketamine in half is as effective as the larger, standard dose in reducing pain in adults.
Researchers at the Keck School of Medicine of the University of Southern California (USC) have discovered key processes by which estrogen, the female sex hormone, activates genes in breast-cancer cells.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANATĀ® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANATĀ® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
› Verified 8 days ago
Dr. Martha Kay Dummer, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2213 Brothers Rd, Suite 600, Santa Fe, NM 87505 Phone: 505-986-8645 Fax: 505-986-8662 | |
Fei Gu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 490a W Zia Rd, Santa Fe, NM 87505 Phone: 505-913-8900 Fax: 505-913-8922 | |
Tudor Ocneanu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2904 Rodeo Park Dr E Ste 300b, Santa Fe, NM 87505 Phone: 505-216-3466 Fax: 505-216-3105 | |
Dr. Joshua Sterling Brown, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1650 Hospital Dr, Suite 200, Santa Fe, NM 87505 Phone: 505-982-4276 Fax: 505-983-7571 | |
Chelsea M Hollander, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 454 St. Michaels Dr. Ste 200, Santa Fe, NM 87505 Phone: 505-303-5000 Fax: 914-242-1516 | |
Dr. Hillary Elizabeth Norton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 404 Brunn School Rd, Ste D, Santa Fe, NM 87505 Phone: 505-988-7568 Fax: 505-988-7569 | |
Dr. Steven Arnold Jenison, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1190 S Saint Francis Dr, Runnels Building S1150, Santa Fe, NM 87505 Phone: 505-476-3668 Fax: 505-827-0163 |